Genmab saw the highest growth of 1.59% in patent filings in April and 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.59% and grants by 0.24%. GlobalData’s DataBook provides a comprehensive analysis of Genmab‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Genmab has been focused on protecting inventions in United States(US) with 11 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 56% filings and 50% grants. The United States(US), China(CN), and South Korea(KR) patent Office are among the top ten patent offices where Genmab is filings its patents. Among the top granted patent authorities, Genmab has 50% of its grants in United States(US) and 50% in China(CN).
Roche could be the strongest competitor for Genmab
Patents related to rare diseases and cell & gene therapy lead Genmab's portfolio
Genmab has the highest number of patents in rare diseases followed by, cell & gene therapy and virtual reality. For rare diseases, nearly 70% of patents were filed and 100% of patents were granted in Q2 2024.
Lymphoma related patents lead Genmab portfolio followed by leukemia, and multiple myeloma (kahler disease)
Genmab has highest number of patents in lymphoma followed by leukemia, multiple myeloma (kahler disease), breast cancer, and rheumatoid arthritis. For lymphoma, nearly 4% of patents were filed and 7% of patents were granted in Q2 2024.
For comprehensive analysis of Genmab's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
